Korro Bio Inc (KRRO)

Apr 29, 2025

Cantor Fitzgerald sets $74 target on Korro Bio stock with Overweight rating - Investing.com

Apr 29, 2025

Apr 19, 2025

Korro Bio (NASDAQ:KRRO) Research Coverage Started at Chardan Capital - Defense World

Apr 19, 2025

Apr 16, 2025

Chardan sets $25 target on Korro Bio stock with Buy rating - Investing.com Australia

Apr 16, 2025

Apr 16, 2025

Chardan Capital Initiates Coverage of Korro Bio (KRRO) with Buy Recommendation - Nasdaq

Apr 16, 2025

Apr 16, 2025

Chardan Initiates Korro Bio at Buy With $25 Price Target - marketscreener.com

Apr 16, 2025

Apr 16, 2025

This UroGen Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga

Apr 16, 2025

Apr 15, 2025

Korro Bio, Inc. (NASDAQ:KRRO) Shares Bought by Wellington Management Group LLP - Defense World

Apr 15, 2025

Apr 14, 2025

Korro Bio, Inc. (NASDAQ:KRRO) Given Consensus Rating of “Buy” by Brokerages - Defense World

Apr 14, 2025

Apr 12, 2025

KLP Kapitalforvaltning AS Purchases New Position in Korro Bio, Inc. (NASDAQ:KRRO) - Defense World

Apr 12, 2025

Apr 11, 2025

Kemi Olugemo '87 Named Chief Medical Officer at Korro Bio - UMass Lowell

Apr 11, 2025

Apr 09, 2025

Raymond James Financial Inc. Purchases New Shares in Korro Bio, Inc. (NASDAQ:KRRO) - Defense World

Apr 09, 2025

Apr 01, 2025

Korro Bio appoints new Chief Scientific Officer By Investing.com - Investing.com South Africa

Apr 01, 2025

Apr 01, 2025

Korro Appoints Loïc Vincent, Ph.D., as Chief Scientific Officer - citybiz

Apr 01, 2025

Apr 01, 2025

Korro Bio appoints new Chief Scientific Officer - Investing.com

Apr 01, 2025

Apr 01, 2025

Korro Appoints Biotech Industry Veteran, Loïc Vincent, Ph.D., as Chief Scientific Officer - The Manila Times

Apr 01, 2025

Apr 01, 2025

RNA-Editing Pioneer Korro Bio Lands Elite CSO with 20+ Drug Development Success Record - Stock Titan

Apr 01, 2025

Mar 31, 2025

Swiss National Bank Acquires Shares of 10,000 Korro Bio, Inc. (NASDAQ:KRRO) - Defense World

Mar 31, 2025

Mar 28, 2025

Korro Bio: Promising Early Stage RNA Editing Company (NASDAQ:KRRO) - Seeking Alpha

Mar 28, 2025

Mar 28, 2025

Korro Bio reappoints CFO, names new principal accounting officer By Investing.com - Investing.com Canada

Mar 28, 2025

Mar 27, 2025

Korro Bio CFO Returns from Medical Leave - TipRanks

Mar 27, 2025

Mar 27, 2025

Korro Bio reappoints CFO, names new principal accounting officer - Investing.com

Mar 27, 2025

Mar 27, 2025

Korro Bio Inc Vineet Agarwal Ends Temporary Medical Leave As CFO - MarketScreener

Mar 27, 2025

Mar 25, 2025

HC Wainwright Has Negative Outlook for Korro Bio Q1 Earnings - The AM Reporter

Mar 25, 2025

Mar 24, 2025

Research Analysts Set Expectations for Korro Bio Q1 Earnings - Defense World

Mar 24, 2025

Mar 24, 2025

Korro Bio (KRRO) Gets a Buy from Piper Sandler - The Globe and Mail

Mar 24, 2025

Mar 23, 2025

Q1 Earnings Forecast for Korro Bio Issued By William Blair - Armenian Reporter

Mar 23, 2025

Mar 22, 2025

HC Wainwright Reiterates Buy Rating for Korro Bio (NASDAQ:KRRO) - Defense World

Mar 22, 2025

Mar 22, 2025

Q1 Earnings Estimate for Korro Bio Issued By William Blair - Defense World

Mar 22, 2025

Mar 21, 2025

Royal Bank of Canada Has Lowered Expectations for Korro Bio (NASDAQ:KRRO) Stock Price - Defense World

Mar 21, 2025

Mar 21, 2025

Korro Bio Reports 2024 Financial Results and Progress - TipRanks

Mar 21, 2025

Mar 20, 2025

H.C. Wainwright maintains Buy rating on Korro Bio stock By Investing.com - Investing.com Australia

Mar 20, 2025

Mar 20, 2025

H.C. Wainwright maintains Buy rating on Korro Bio stock - Investing.com

Mar 20, 2025

Mar 20, 2025

Korro Bio, Inc. (NASDAQ:KRRO) Given Consensus Recommendation of “Buy” by Analysts - Defense World

Mar 20, 2025

Mar 19, 2025

Korro Bio’s SWOT analysis: RNA editing firm’s stock poised for growth - Investing.com Australia

Mar 19, 2025

Mar 19, 2025

Korro Bio’s SWOT analysis: RNA editing firm’s stock poised for growth By Investing.com - Investing.com South Africa

Mar 19, 2025

Mar 19, 2025

Is Korro Bio (NASDAQ:KRRO) In A Good Position To Invest In Growth? - Yahoo

Mar 19, 2025

Mar 19, 2025

RBC Cuts Price Target on Korro Bio to $95 From $105, Keeps Outperform, Speculative Risk - Marketscreener.com

Mar 19, 2025

Mar 18, 2025

Korro Bio, Inc. SEC 10-K Report - TradingView

Mar 18, 2025

Mar 18, 2025

Korro Reports Full Year 2024 Financial Results and Provides Business Updates - The Manila Times

Mar 18, 2025

Mar 18, 2025

Korro Bio Reports Clean Safety Data in AATD Drug Trial, Secures $163M Runway - StockTitan

Mar 18, 2025

Mar 18, 2025

Korro Bio (KRRO) Projected to Post Earnings on Tuesday - Defense World

Mar 18, 2025

Mar 15, 2025

FDA grants orphan drug status to Korro’s AATD treatment By Investing.com - Investing.com Australia

Mar 15, 2025

Mar 14, 2025

Korro Bio gets FDA Orphan Drug tag (KRRO:NASDAQ) - Seeking Alpha

Mar 14, 2025

Mar 14, 2025

Korro Bio's Potential Antitrypsin Deficiency Treatment Receives US FDA Orphan Drug Designation - Marketscreener.com

Mar 14, 2025

Mar 14, 2025

FDA grants orphan drug status to Korro’s AATD treatment - Investing.com

Mar 14, 2025

Mar 14, 2025

KRRO-110 Receives Orphan Drug Designation from U.S. FDA for Alpha-1 Antitrypsin Deficiency - The Manila Times

Mar 14, 2025

Mar 14, 2025

Breakthrough for Rare Disease: FDA Awards Special Status to Korro Bio's Novel RNA Treatment - StockTitan

Mar 14, 2025

Mar 10, 2025

Rhumbline Advisers Purchases 691 Shares of Korro Bio, Inc. (NASDAQ:KRRO) - Defense World

Mar 10, 2025